Naga Chalasani
Indiana University Bloomington
H-index: 111
North America-United States
Top articles of Naga Chalasani
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Clinical characteristics and prognosis of hospitalized patients with moderate alcohol‐associated hepatitis | Liver International | Maria Gaurnizo‐Ortiz Lauren D Nephew Eduardo Vilar‐Gomez Carla D Kettler James E Slaven | 2024/1 |
Role of spleen stiffness measurement in the evaluation of metabolic dysfunction-associated steatotic liver disease | Digestive Diseases and Sciences | Elizabeth E Williams Andrea Mladenovic Dheeksha Ranginani Regina Weber Niharika Samala | 2024/2/8 |
Prevalence of steatotic liver disease, MASLD, MetALD and significant fibrosis in people with HIV in the United States | Alimentary Pharmacology & Therapeutics | Samer Gawrieh Eduardo Vilar‐Gomez Tinsay A Woreta Jordan E Lake Laura A Wilson | 2024/3 |
Age, BMI, and Type 2 Diabetes Modify the Relationship Between PNPLA3 and Advanced Fibrosis in Children and Adults With NAFLD | Clinical Gastroenterology and Hepatology | Chaowapong Jarasvaraparn Eduardo Vilar-Gomez Katherine P Yates Laura A Wilson Brent Neuschwander-Tetri | 2024/5/1 |
Liver biopsy for assessment of suspected drug‐induced liver injury in metabolic dysfunction‐associated steatohepatitis clinical trials: Expert consensus from the Liver Forum | Alimentary Pharmacology & Therapeutics | Melissa Palmer David E Kleiner Zachary Goodman Elizabeth Brunt Mark I Avigan | 2024/1 |
Response to Rollins and Abaza | Official journal of the American College of Gastroenterology| ACG | Naga Chalasani Elizabeth Phillips Paola Nicoletti | 2024/2/1 |
Amiodarone and Dronedarone Causes Liver Injury with Distinctly Different Clinical Presentations | Digestive Diseases and Sciences | Alexander Pop Dina Halegoua-DeMarzio Huiman Barnhart David Kleiner Mark Avigan | 2024/2/28 |
PNPLA3 rs738409, age, diabetes, sex, and advanced fibrosis jointly contribute to the risk of major adverse liver outcomes in metabolic-associated steatotic liver disease | Hepatology | Naga Chalasani Eduardo Vilar-Gomez Rohit Loomba Katherine P Yates Anna Mae Diehl | 2024/4/23 |
Vancomycin-Induced Liver Injury, DRESS, and HLA-A∗ 32: 01 | The Journal of Allergy and Clinical Immunology: In Practice | Bilal A Asif Christopher Koh Elizabeth J Phillips Jiezhun Gu Yi-Ju Li | 2024/1/1 |
A 68-Year-Old Woman With Unexplained Liver Enzyme Elevation and Active Chronic Hepatitis: Beware of Drug-Induced Autoimmune-Like Hepatitis | Gastroenterology | Lily Dara Marwan Ghabril Elizabeth Phillips David Kleiner Naga Chalasani | 2024/2/1 |
Primary sclerosing cholangitis limited to intrahepatic bile ducts has distinctly better prognosis | Digestive Diseases and Sciences | Vijay S Are Mark A Gromski Fatih Akisik Eduardo Vilar-Gomez Craig Lammert | 2024/2/12 |
The effects of food insecurity on hepatic steatosis and fibrosis in people with HIV | Clinical Gastroenterology and Hepatology | Ani Kardashian Audrey Lloyd Eduardo Vilar-Gomez Susanna Naggie Mark S Sulkowski | 2024/4/5 |
Severe hepatic encephalopathy with mechanical ventilation may inform waitlist priority in acute liver failure: A UNOS database analysis | Clinical Transplantation | Jiayi Ma James E Slaven Lauren Nephew Kavish R Patidar Archita P Desai | 2024/1 |
Occult liver disease: a multinational perspective | Annals of Hepatology | Paulina Vidal-Cevallos Nayelli Flores-García Norberto C Chávez-Tapia Naga P Chalasani | 2024/2/12 |
WJH | World | Huey K Tan Euan Yates Kristen Lilly Ashwin D Dhanda T Suga | 2020/7/27 |
Hospital frailty risk score is superior to legacy comorbidity indices for risk adjustment of in-hospital cirrhosis cases | JHEP Reports | Archita P Desai Swetha Parvataneni Shannon M Knapp Lauren D Nephew Naga Chalasani | 2024/1/1 |
Randomized trial of anakinra plus zinc vs. prednisone for severe alcohol-associated hepatitis | Journal of Hepatology | Samer Gawrieh Srinivasan Dasarathy Wanzhu Tu Patrick S Kamath Naga P Chalasani | 2024/2/10 |
Updated epidemiology of steatotic liver disease in people with HIV in the United States—Authors' reply | Richie Manikat Seung Up Kim Aijaz Ahmed Donghee Kim | 2024/3 | |
Drug-induced Liver Injury from Hormonal and Non-hormonal Therapies: Insights from a Large Case Series | Journal of Clinical and Experimental Hepatology | Raj Vuppalanchi Naga Chalasani | 2024/5/1 |
Using a Proteomics-Based Cardiovascular Risk Test to Identify Systemic Changes in a Clinical Trial of Nonalcoholic Fatty Liver Disease | Circulation | Arun Sanyal Missy Simpson Michael Hinterberg Erin Hales Clare Paterson | 2023/11/7 |
